NCT03025256 2026-04-02
Intravenous and Intrathecal Nivolumab in Treating Patients With Leptomeningeal Disease
M.D. Anderson Cancer Center
Phase 1 Recruiting
M.D. Anderson Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
AstraZeneca
Plus Therapeutics
University Hospital Tuebingen